Choose An Infectious Disease That Is Currently A Huma 353018

Choose An Infectious Disease That Is Currently A Human Health Riskres

Choose an infectious disease that is currently a human health risk. Research your topic using online sources such as the NIH, CDC, and WHO. Write a 350- to 525-word blog entry on the disease. You are getting the word out to your chosen audience. Answer the following questions: Describe the cause and symptoms of the disease.

Which populations are most susceptible to infection? How is the disease transmitted? Is there a vaccine or treatment available for the disease? Is the disease new or has it occurred in the past? Does the disease present a significant problem for the human population globally, or is it localized? Format the reference consistent with APA guidelines.

Paper For Above instruction

Choose An Infectious Disease That Is Currently A Human Health Riskres

Choose An Infectious Disease That Is Currently A Human Health Riskres

Infectious diseases continue to pose significant threats to global health, with emerging and re-emerging pathogens challenging healthcare systems worldwide. One such disease that currently presents a substantial human health risk is COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Understanding the nature of this disease, its transmission, impact on different populations, and available countermeasures is crucial in the ongoing effort to mitigate its effects.

Cause and Symptoms

COVID-19 is caused by the novel coronavirus SARS-CoV-2. The virus primarily targets the respiratory system, entering human cells through the ACE2 receptors. Symptoms vary widely, ranging from mild to severe respiratory issues. Common signs include fever, cough, shortness of breath, fatigue, loss of taste or smell, muscle aches, and sore throat. Severe cases can lead to pneumonia, acute respiratory distress syndrome (ARDS), organ failure, and death. The disease's incubation period ranges from 2 to 14 days post-exposure, complicating containment efforts.

Susceptible Populations and Transmission

While COVID-19 can infect individuals of all ages, certain populations are more vulnerable. Older adults, particularly those over 65, and individuals with pre-existing health conditions such as cardiovascular disease, diabetes, obesity, or compromised immune systems are at higher risk of severe illness and mortality. The virus transmits primarily through respiratory droplets expelled when infected individuals cough, sneeze, talk, or breathe. Transmission can also occur via contact with contaminated surfaces, although this is less common. Asymptomatic carriers further complicate efforts to control spread, emphasizing the importance of preventive measures.

Prevention and Treatment

Multiple vaccines have been developed and are widely administered globally, significantly reducing the incidence of severe disease and death. Vaccines such as Pfizer-BioNTech, Moderna, and Johnson & Johnson have demonstrated high efficacy. Unfortunately, no specific antiviral treatment cures COVID-19. Care mainly involves supportive therapies to manage symptoms, oxygen supplementation, and, in severe cases, mechanical ventilation. The emergence of antiviral drugs like remdesivir and corticosteroids has improved clinical outcomes, but management remains primarily supportive.

Historical Context and Global Impact

COVID-19 was first identified in Wuhan, China, in late 2019, and rapidly spread worldwide, leading to a global pandemic declared by the World Health Organization (WHO) in March 2020. Its unprecedented scale and severity underscore its significance as a human health crisis. While initially localized, the disease has since become a global concern, affecting economies, healthcare systems, and daily life across all continents. The ongoing emergence of variants and vaccine hesitancy continue to pose challenges, emphasizing the need for continued public health efforts and global cooperation.

Conclusion

COVID-19 exemplifies a modern infectious disease with profound impacts globally. Its rapid transmission, susceptibility of vulnerable populations, and the need for persistent public health interventions highlight the importance of ongoing research, vaccination campaigns, and international collaboration to control and eventually eradicate its threat to human health.

References

  • World Health Organization. (2023). COVID-19 pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  • Centers for Disease Control and Prevention. (2023). COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/index.html
  • Johns Hopkins University & Medicine. (2023). COVID-19 Dashboard. https://coronavirus.jhu.edu/map.html
  • Gorbalenya, A. E., et al. (2020). The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 5(4), 536-544.
  • Li, Q., et al. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine, 382(13), 1199-1207.
  • Bock, K., et al. (2021). Vaccination strategies against COVID-19: An update. Vaccine, 39(22), 3012-3022.
  • Huang, C., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497-506.
  • Motsoeneng, M. F., et al. (2021). Emerging variants of concern and their impact on COVID-19 vaccines. Nature Reviews Immunology, 21(9), 533-534.
  • Fauci, A. S., et al. (2020). The ongoing challenge of COVID-19: Vaccines and therapeutics. Journal of Clinical Investigation, 130(12), 5853-5857.
  • World Health Organization. (2022). COVID-19 vaccines. https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines

Related Assignments